<DOC>
	<DOCNO>NCT00630370</DOCNO>
	<brief_summary>To assess efficacy 3 oral dose regimen ATI 7505 compare placebo patient PDS compare end Day 42 percentage patient treatment group adequate relief postprandial distress syndrome symptom least 50 % treatment day .</brief_summary>
	<brief_title>A Dose-Ranging Study ATI 7505 Patients With Postprandial Distress Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>ATI 7505</mesh_term>
	<criteria>Were diagnose PDS least 6 month prior screen , OR onset 2 PDS symptom least 6 month prior screen . Experienced early satiety bothersome postprandial fullness repeatedly 3 month prior screen . Had normal upper GI endoscopy within past year . Heartburn occur &gt; 3 time per week Current Helicobacter pylorus ( H pylorus ) infection confirm stool sample test breath testing , H pylori eradication therapy within 6 month prior screen Any alarm symptom include uninvestigated anemia , rectal bleeding , weight loss , unresolved fever within 6 month prior screen At screening , QT interval correct heart rate use Bazett 's correction formula ( QTcB ) &gt; 440 msec determine Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>